• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球范围内与高身体质量指数相关的疾病负担及其国家间不平等:2019 年全球疾病负担研究结果。

Global burden and cross-country inequalities in diseases associated with high body mass index from 1990 to 2019: Result from the Global Burden of Disease Study 2019.

机构信息

Department of Gastroenterology, the Affiliated Hospital of Southwest Medical University, Luzhou, China.

Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China.

出版信息

J Glob Health. 2024 Nov 8;14:04200. doi: 10.7189/jogh.14.04200.

DOI:10.7189/jogh.14.04200
PMID:39513280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11544517/
Abstract

BACKGROUND

High body mass index (BMI) has gradually become an increased risk factor for the global burden of diseases (GBD). As the disease burden and the number of elders globally increase, it is crucial for policymakers to realise the associations between high BMI and disease burden worldwide in a timely manner and to develop effective interventions for different countries and ages.

METHODS

We used the GBD 2019 database to analyse the deaths and disability-adjusted life-years (DALYs) in the disease burden associated with high BMI and indicated the health inequality at the global, regional, and national levels. We applied the slope index of inequality and concentration index, two standard metrics of absolute and relative gradient inequality recommended by the World Health Organization (WHO), to quantify the distributive inequalities in the burden of diseases associated with high BMI. These rates were reported per 100 000 population as crude incidence rates, death rates, and DALYs rates. All the estimates were generated with a 95% uncertainty interval (UIs).

RESULTS

Globally, we revealed that an estimated age-standardised mortality rate associated with high BMI is 6.26 million (95% UIs = 3.99, 8.91). The age-standardised DALYs rate is 19.32 million (95% UIs = 12.77, 26.40), and the global population attributable fraction was 9% (95% UIs = 5, 12) in 2019. The largest number of high-BMI-related deaths in women mainly concentrated in the age group of 65-79 years, whereas the largest number in men was in the age group of 60-69 years. The age-standardised DALYs rate of diseases associated with high BMI was larger in the high-middle and middle socio-demographic index (SDI) (population attributable fraction (PAF) = 11 and PAF = 9) regions than those with high SDI (PAF = 1) and low SDI (PAF = 5) regions.

CONCLUSIONS

In this study, our results showed that the disease burden of global deaths and DALYs associated with high BMI has substantially increased between 1990-2019. Furthermore, we demonstrated that countries with higher SDI development levels shoulders higher burden of diseases associated with high BMI. Future policies to prevent and reduce the burden should be developed and implemented based on country-specific development status.

摘要

背景

高身体质量指数(BMI)逐渐成为全球疾病负担(GBD)的一个危险因素。随着全球疾病负担和老年人数量的增加,政策制定者及时了解全球范围内高 BMI 与疾病负担之间的关联,并为不同国家和年龄段制定有效的干预措施至关重要。

方法

我们使用 GBD 2019 数据库分析了与高 BMI 相关的疾病负担的死亡人数和伤残调整生命年(DALYs),并指出了全球、区域和国家各级的健康不平等情况。我们应用了不平等斜率指数和集中指数这两个世界卫生组织(WHO)推荐的衡量绝对和相对梯度不平等的标准指标,来量化与高 BMI 相关的疾病负担的分布不平等情况。这些比率以每 100000 人口的粗发病率、死亡率和 DALYs 率报告。所有估计均使用 95%置信区间(UI)生成。

结果

在全球范围内,我们发现与高 BMI 相关的年龄标准化死亡率估计为 626 万(95%UI=399,891)。年龄标准化 DALYs 率为 1932 万(95%UI=1277,2640),全球归因分数为 9%(95%UI=5,12)。2019 年,女性中与高 BMI 相关的死亡人数最多,主要集中在 65-79 岁年龄组,而男性中死亡人数最多的年龄组为 60-69 岁。高-中社会人口指数(SDI)(归因分数(PAF)=11 和 PAF=9)地区与高 SDI(PAF=1)和低 SDI(PAF=5)地区相比,高 BMI 相关疾病的年龄标准化 DALYs 率更大。

结论

在这项研究中,我们的结果表明,1990-2019 年期间,全球与高 BMI 相关的死亡人数和 DALYs 的疾病负担大幅增加。此外,我们表明,SDI 发展水平较高的国家承担着与高 BMI 相关的更高的疾病负担。未来应根据各国的发展状况制定和实施预防和减少负担的政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/5ec82a5d393e/jogh-14-04200-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/493c0c939a9d/jogh-14-04200-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/e411dd27b6f4/jogh-14-04200-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/60767291fc8a/jogh-14-04200-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/5cd0d589574a/jogh-14-04200-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/2fac925976e7/jogh-14-04200-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/5ec82a5d393e/jogh-14-04200-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/493c0c939a9d/jogh-14-04200-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/e411dd27b6f4/jogh-14-04200-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/60767291fc8a/jogh-14-04200-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/5cd0d589574a/jogh-14-04200-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/2fac925976e7/jogh-14-04200-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dc6/11544517/5ec82a5d393e/jogh-14-04200-F6.jpg

相似文献

1
Global burden and cross-country inequalities in diseases associated with high body mass index from 1990 to 2019: Result from the Global Burden of Disease Study 2019.全球范围内与高身体质量指数相关的疾病负担及其国家间不平等:2019 年全球疾病负担研究结果。
J Glob Health. 2024 Nov 8;14:04200. doi: 10.7189/jogh.14.04200.
2
The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.2019 年全球 195 个国家和地区因超重导致的疾病负担:基于全球疾病负担研究的分析。
PLoS Med. 2020 Jul 28;17(7):e1003198. doi: 10.1371/journal.pmed.1003198. eCollection 2020 Jul.
3
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
4
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
5
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
6
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
7
The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035.204 个国家和地区与高身体质量指数相关的全球疾病负担:1990 年至 2019 年的发现和到 2035 年的预测。
Diabetes Obes Metab. 2024 Sep;26(9):3998-4010. doi: 10.1111/dom.15748. Epub 2024 Jul 3.
8
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990—2019年全球、区域和国家的卒中负担及其风险因素:全球疾病负担研究2019的系统分析
Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
9
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.全球、地区和国家慢性阻塞性肺疾病和哮喘的死亡、患病率、残疾调整生命年以及与残疾相关的生命年,1990-2015 年:2015 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16.
10
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年食管痛的全球、区域和国家负担及其可归因风险因素:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1.

引用本文的文献

1
Global trends in Alzheimer's disease and other dementias in adults aged 55 and above (1992-2021): An age-period-cohort analysis based on the GBD 2021.55岁及以上成年人阿尔茨海默病和其他痴呆症的全球趋势(1992 - 2021年):基于全球疾病负担研究(GBD)2021的年龄-时期-队列分析
PLoS One. 2025 Aug 29;20(8):e0331204. doi: 10.1371/journal.pone.0331204. eCollection 2025.
2
Trends and disparities in mortality due to hypertensive disease and coexisting obesity in the USA: 1999-2023.1999 - 2023年美国高血压疾病及并存肥胖导致的死亡率趋势与差异
Egypt Heart J. 2025 Aug 26;77(1):81. doi: 10.1186/s43044-025-00677-5.
3
Trend analysis and future predictions of global burden of alzheimer's disease and other dementias: a study based on the global burden of disease database from 1990 to 2021.

本文引用的文献

1
Burden of diseases attributable to excess body weight in the Middle East and North Africa region, 1990-2019.1990-2019 年归因于超重的疾病负担在中东和北非地区。
Sci Rep. 2023 Nov 20;13(1):20338. doi: 10.1038/s41598-023-46702-y.
2
Changing trends of the diseases burden attributable to high BMI in Asia from 1990 to 2019: results from the global burden of disease study 2019.1990 年至 2019 年亚洲归因于高 BMI 的疾病负担变化趋势:2019 年全球疾病负担研究结果。
BMJ Open. 2023 Oct 21;13(10):e075437. doi: 10.1136/bmjopen-2023-075437.
3
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019.
阿尔茨海默病及其他痴呆症全球负担的趋势分析与未来预测:一项基于1990年至2021年全球疾病负担数据库的研究
BMC Med. 2025 Jul 1;23(1):378. doi: 10.1186/s12916-025-04169-w.
4
Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses.1990年至2021年全球、区域和国家前列腺癌患病率:趋势与健康不平等分析
Front Public Health. 2025 Jun 11;13:1595159. doi: 10.3389/fpubh.2025.1595159. eCollection 2025.
5
Global burden and epidemic trends of chronic kidney disease attributable to high body mass index: insights from the Global Burden of Disease Study 2021.归因于高体重指数的慢性肾脏病的全球负担及流行趋势:来自《2021年全球疾病负担研究》的见解
Ren Fail. 2025 Dec;47(1):2512400. doi: 10.1080/0886022X.2025.2512400. Epub 2025 Jun 8.
6
Evaluation of gut microbiota alterations following orlistat administration in obese mice.奥利司他给药后肥胖小鼠肠道微生物群变化的评估。
Front Endocrinol (Lausanne). 2025 Feb 26;15:1337245. doi: 10.3389/fendo.2024.1337245. eCollection 2024.
全球范围内 1990 年至 2019 年的自身免疫性疾病负担和国家间不平等。
Autoimmun Rev. 2023 Jun;22(6):103326. doi: 10.1016/j.autrev.2023.103326. Epub 2023 Mar 22.
4
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.归因于风险因素的癌症全球负担,2010-19 年:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Aug 20;400(10352):563-591. doi: 10.1016/S0140-6736(22)01438-6.
5
The global burden and temporal trend of cancer attributable to high body mass index: Estimates from the Global Burden of Disease Study 2019.归因于高体重指数的癌症全球负担及时间趋势:来自《2019年全球疾病负担研究》的估计
Front Nutr. 2022 Jul 26;9:918330. doi: 10.3389/fnut.2022.918330. eCollection 2022.
6
Prevalence and Correlates of Overweight and Obesity in 12 European Countries in 2017-2018.2017-2018 年 12 个欧洲国家超重和肥胖的流行率及其相关因素。
Obes Facts. 2022;15(5):655-665. doi: 10.1159/000525792. Epub 2022 Aug 2.
7
Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家结直肠癌及其危险因素负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-647. doi: 10.1016/S2468-1253(22)00044-9. Epub 2022 Apr 7.
8
The nutrition transition, food retail transformations, and policy responses to overnutrition in the East Asia region: A descriptive review.东亚地区的营养转型、食品零售变革及针对营养过剩的政策应对:描述性综述
Obes Rev. 2022 Apr;23(4):e13412. doi: 10.1111/obr.13412. Epub 2022 Jan 4.
9
Health policy and public health implications of obesity in China.中国肥胖问题的健康政策和公共卫生影响。
Lancet Diabetes Endocrinol. 2021 Jul;9(7):446-461. doi: 10.1016/S2213-8587(21)00118-2. Epub 2021 Jun 4.
10
Diet, Nutrition and Chronic Degenerative Diseases.饮食、营养与慢性退行性疾病。
Nutrients. 2021 Apr 20;13(4):1372. doi: 10.3390/nu13041372.